So far in 2025, the Trump administration has cut more than $1 billion in NIH grants. That includes a study on sickle cell ...

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

Sickle cell disease can lead to a severe complication known as acute chest syndrome (ACS), but the underlying mechanisms are ...

Thirty-three states, the District of Columbia, and Puerto Rico will participate in CMS’ voluntary Cell and Gene Therapy (CGT) ...

CMS is brokering outcomes-based agreements on behalf of Medicaid programs. Thirty-three states, along with Washington, D.C., ...

A recalled sickle cell drug is drawing new scrutiny from attorneys who say it may have done more harm than good, possibly ...

According to Coherent Market Insights (CMI), the global sickle cell disease treatment market size is expected to expand from USD 3.20 Bn in 2025 to USD 8.81 Bn by 2032, recording a CAGR of 15.6% ...

Sickle cell disease is one of the most common genetic blood disorders in the world. It affects millions globally, with the ...

Sickle cell disease can lead to a severe complication known as acute chest syndrome (ACS), but the underlying mechanisms are not well understood. A ...

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

The US regulator has launched a new national initiative to help Medicaid programs fund gene therapies for sickle cell disease ...

SHREVEPORT, La. - An estimated 100,000 people in the United States have sickle cell disease, according to the Sickle Cell ...